Lactoferrin 17-41 |
| Katalog-Nr.GC36418 |
Lactoferrin 17-41 (Lactoferricin B), ein Peptid, das den Resten 17-41 von Rinder-Lactoferrin entspricht, hat eine antimikrobielle Aktivität gegen eine Vielzahl von Mikroorganismen, einschließlich grampositiver und gramnegativer Bakterien, Viren, Protozoen und Pilze.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 146897-68-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Lactoferrin 17-41, known as lactoferricin B (LfcinB), corresponds to residues 17-41 of bovine lactoferrin, has antimicrobial and antitumor activities[1][2].
[1]. Samuelsen Ø, et al. Anti-complement effects of lactoferrin-derived peptides. FEMS Immunol Med Microbiol. 2004 Jun 1;41(2):141-8. [2]. Jiang R, et al. Bovine lactoferrin and lactoferricin exert antitumor activities on human colorectal cancer cells(HT-29) by activating various signaling pathways. Biochem Cell Biol. 2017 Feb;95(1):99-109.
Average Rating: 5 (Based on Reviews and 34 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *